Last reviewed · How we verify
Idiopathic generalized epilepsy
Approved treatments
- Fycompa · Catalyst Pharms
Fycompa works by blocking the AMPA glutamate receptor, which is involved in the transmission of nerve impulses. - Vimpat · UCB
- Fycompa · Eisai Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Idiopathic generalized epilepsy patent landscape — cliff calendar, originator estates, attackable patents
- Idiopathic generalized epilepsy treatment landscape brief
- Idiopathic generalized epilepsy treatment updates RSS
Frequently asked questions about Idiopathic generalized epilepsy
What drugs treat Idiopathic generalized epilepsy?
Tracked treatments include Fycompa, Vimpat.
What is the treatment for Idiopathic generalized epilepsy?
Standard treatment for Idiopathic generalized epilepsy includes Fycompa, Vimpat. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Idiopathic generalized epilepsy patent cliff · Idiopathic generalized epilepsy CI report
- Treatment: Fycompa · Catalyst Pharms
- Treatment: Vimpat · UCB
- Treatment: Fycompa · Eisai Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing